Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Showing 1–5 of 10 stories
Latest story
The agreement grants Nxera exclusive development and commercialization rights for the investigationa...
Read story
Late-breaking data presented at ACR Convergence 2026 show that investigational URAT1 inhibitor pozde...
Read story
Mundipharma has announced additional results from the Phase 3 ReSPECT clinical trial evaluating Rezz...
Read story
Roche has announced positive Phase III results from the ongoing IMAgINATION study evaluating investi...
Read story
The research collaboration aims to improve preclinical methods for evaluating the abuse potential of...
Read storyPage 1 of 2